Distribution of substance P and vasoactive intestinal peptide in the human liver: light and electron immunoperoxidase methods of observation.

Takato Ueno(Kurume University), Vı́ctor Tsutsumi, Ryuichiro Sakata(Kurume University), Masaharu Sakamoto(Kurume University), Sadataka Inuzuka, Kazuhisa Gondo(Yanagawa Rehabilitation Hospital), Toshichika Aoki, Kyuichi Tanikawa(Kurume University), Takuji Torimura(Omuta hospital)
PubMed
November 1, 1991
Cited by 54

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504
MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
|Liver International|2020|410